Large Molecule
Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis
Waters Corporation
PR-10-24-NI-38Oct 11, 2024
Accelerating Product Development
What strategies are being employed to accelerate product development and commercialization without compromising quality?
Pharma's Almanac
PAO-03-24-CL-02Mar 08, 2024
Bioprocess Analytics
Collaboration is Key to the Development of Effective Bioprocess Analysis Solutions to Address Complex Data Needs
Nick Pittman; Magnus Wetterhall, Ph.D.
Waters Corporation
PAO-06-23-CL-07Jul 10, 2023
Wexford R&D Facility
Expanding R&D to Meet Challenges in Biopharmaceutical Processes
Waters Corporation
PAO-02-23-PATV-02Feb 14, 2023
Disruptive Technology
What do you view as the most disruptive or transformational technology or development on the horizon?
Pharma's Almanac
PAO-01-23-RT-01Jan 31, 2023
Leadership
Q: What’s the key to being a leader in the industry?
Pharma's Almanac
PAO-03-022-RT-02Mar 11, 2022
Milestones
Q: What important company milestone do you anticipate reaching in 2022?
Pharma's Almanac
PAO-03-022-RT-01Mar 11, 2022
Automation
Advancing the Science of What's Possible
Waters Corporation
PAO-02-22-R250-13Feb 11, 2022